Dawn Giangiulio - 13 Aug 2021 Form 3 Insider Report for Design Therapeutics, Inc. (DSGN)

Role: Principal Accounting Officer
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol: DSGN
Transactions as of: 13 Aug 2021
Net transactions value: $0
Form type: 3
Filing time: 17 Aug 2021, 19:21:48 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DSGN	Common Stock						7,500	13 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DSGN	Stock option (right to buy)							13 Aug 2021	Common Stock	12,269	$0.9500	Direct	F1
holding	DSGN	Stock option (right to buy)							13 Aug 2021	Common stock	24,539	$0.9500	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares vested on March 30, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.
F2	25% of the shares shall vest on December 7, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.